Acrolein toxicity at advanced age: present and future

被引:38
|
作者
Igarashi, Kazuei [1 ,2 ]
Uemura, Takeshi [1 ,2 ]
Kashiwagi, Keiko [3 ]
机构
[1] Chiba Univ, Amine Pharma Res Inst, Chuo Ku, Innovat Plaza,1-8-15 Inohana, Chiba, Chiba 2600856, Japan
[2] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608675, Japan
[3] Chiba Inst Sci, Fac Pharm, 15-8 Shiomi Cho, Choshi, Chiba 2880025, Japan
关键词
Acrolein; Polyamines; Brain infarction; Glutathione; Reactive oxygen species (ROS); PRIMARY SJOGRENS-SYNDROME; PROTEIN-CONJUGATED ACROLEIN; MILD COGNITIVE IMPAIRMENT; SILENT BRAIN INFARCTION; MATRIX METALLOPROTEINASES; ALZHEIMERS-DISEASE; GELATINASE-B; CELL-DEATH; POLYAMINES; STROKE;
D O I
10.1007/s00726-017-2527-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is thought that tissue damage at advanced age is mainly caused by ROS (reactive oxygen species, O-2 (-), H2O2, and center dot OH). However, it was found that acrolein (CH2=CH-CHO) is more toxic than ROS, and is mainly produced from spermine (SPM), one of the polyamines, rather than from unsaturated fatty acids. Significant amounts of SPM are present normally as SPM-ribosome complexes, and contribute to protein synthesis. However, SPM was released from ribosomes due to the degradation of ribosomal RNA by center dot OH or the binding of Ca2+ to ribosomes, and acrolein was produced from free SPM by polyamine oxidases, particularly by SPM oxidase. Acrolein inactivated several proteins such as GAPDH (glycelaldehyde-3-phosphate dehydrogenase), and also stimulated MMP-9 (matrix metalloproteinase-9) activity. Acrolein-conjugated GAPDH translocated to nucleus, and caused apoptosis like nitrosylated GAPDH. Through acrolein conjugation with several proteins, acrolein causes tissue damage during brain stroke, dementia, renal failure, and primary Sjogren's syndrome. Thus, development of acrolein scavengers with less side effects is very important to maintain QOL (quality of life) of elderly people.
引用
收藏
页码:217 / 228
页数:12
相关论文
共 50 条
  • [1] Acrolein toxicity at advanced age: present and future
    Kazuei Igarashi
    Takeshi Uemura
    Keiko Kashiwagi
    Amino Acids, 2018, 50 : 217 - 228
  • [2] Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment
    Ubaldi, Filippo Maria
    Cimadomo, Danilo
    Vaiarelli, Alberto
    Fabozzi, Gemma
    Venturella, Roberta
    Maggiulli, Roberta
    Mazzilli, Rossella
    Ferrero, Susanna
    Palagiano, Antonio
    Rienzi, Laura
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [3] Aluminum Toxicity in Plants: Present and Future
    Hajiboland, Roghieh
    Panda, Chetan K.
    Lastochkina, Oksana
    Gavassi, Marina A.
    Habermann, Gustavo
    Pereira, Jorge F.
    JOURNAL OF PLANT GROWTH REGULATION, 2023, 42 (07) : 3967 - 3999
  • [4] Aluminum Toxicity in Plants: Present and Future
    Roghieh Hajiboland
    Chetan K. Panda
    Oksana Lastochkina
    Marina A. Gavassi
    Gustavo Habermann
    Jorge F. Pereira
    Journal of Plant Growth Regulation, 2023, 42 : 3967 - 3999
  • [5] PRESENT AND FUTURE AGE STRUCTURE
    HEINRICH, R
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1995, 257 (1-4) : 76 - 82
  • [6] Present and future advanced laparoscopic surgery
    Rivas, Homero
    Diaz-Calderon, Daniela
    ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 2013, 6 (02) : 59 - 67
  • [7] Advanced Manufacturing: Past, Present and Future
    Plumb, Steve
    MANUFACTURING ENGINEERING, 2022, 169 (05): : 15 - 16
  • [8] ADVANCED EDUCATION - PAST, PRESENT, AND FUTURE
    HAMBURGER, F
    IRE TRANSACTIONS ON EDUCATION, 1959, 2 (02): : 31 - 37
  • [9] ADVANCED PLACEMENT - PAST, PRESENT, AND FUTURE
    FRANKLIN, MP
    EDUCATIONAL FORUM, 1965, 29 (03): : 349 - 353
  • [10] Assessing sediment toxicity: Past, present, and future
    Burton, G. Allen, Jr.
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2013, 32 (07) : 1438 - 1440